Bone Resorption

The supplied grounding supports bone resorption as part of physiological bone remodeling and as a feature of osteoporosis-related bone loss. It also links increased bone resorption to estrogen deficiency and to excessive glucocorticoid use in osteoporosis.

Bone resorption is mediated by osteoclasts within the bone remodeling cycle, which proceeds through activation, resorption, reversal, formation, and termination. In disease states, an imbalance between bone resorption and bone formation increases bone turnover and leads to demineralization and loss of bone mass.

The grounding identifies postmenopausal status, older age, estrogen deficiency, and excessive glucocorticoid use as factors associated with increased bone loss and osteoporosis-related resorption. It also notes harmful habits such as high alcohol consumption and smoking in the context of osteoporosis management.

Management is described at the class and modality level as anti-resorptive drugs for pharmacologic treatment. The grounding also mentions emerging regenerative medicine approaches such as cell therapies and bioactive hydrogels, alongside non-pharmacological measures including physical activity, diet, and cessation of smoking and high alcohol use.